Stocks
By market cap · 57 stocks
- 1
AbbottABTFreeStyle Libre, cardiovascular devices, diagnostics, and nutrition$194.62B+0.77% - 2
DanaherDHRBioprocessing, life-science, and clinical diagnostics portfolio$151.89B+0.17% - 3
NateraNTRAMolecular testing across pregnancy, cancer, and organ health$46.73B−3.71% - 4
IlluminaILMNSequencing and array platform with recurring consumables$32.62B−5.29% - 5
Quest DiagnosticsDGXClinical testing and diagnostic laboratory network$26.79B−0.73% - 6
Philips (ADR)PHGClinical imaging, connected care, and personal health$26.12B−0.80% - 7
Guardant HealthGHCancer blood tests for screening, monitoring, and treatment$21.67B−4.14% - 8
RevvityRVTYLife-science research and clinical diagnostics supplier$14.37B−0.69% - 9
Bio-Rad LaboratoriesBIODroplet digital PCR and clinical-lab systems$10.44B−0.59% - 10
QIAGENQGENSample-to-Insight molecular testing workflow provider$8.89B−1.42% - 11
Twist BioscienceTWSTSilicon-based DNA synthesis and sequencing tools$8.80B−7.72% - 12
Grifols (ADR)GRFSIntegrated plasma therapies and diagnostics$6.51B−1.66% - 13
MiniMed GroupMMEDIntegrated insulin delivery and glucose monitoring$5.64B+2.92% - 14
HaemoneticsHAEPlasma collection and hospital blood-management devices$4.72B−1.06% - 15
CelcuityCELCDeveloper of REVTORPYK for advanced breast cancer$4.31B−5.08% - 16
BillionToOneBLLNMaker of prenatal and cancer genetic tests$4.29B−1.94% - 17
Adaptive BiotechnologiesADPTImmune-receptor sequencing for residual-disease testing$4.03B−4.65% - 18
VeracyteVCYTGenomic cancer tests from diagnosis through recurrence$3.46B−4.24% - 19
GRAILGRALDeveloper of Galleri multi-cancer blood screening$3.43B−3.02% - 20
Alamar BiosciencesALMRNULISA-based precision proteomics platform provider$2.13B−6.88% - 21
OPKO HealthOPKBioReference diagnostics and biopharma operator$1.10B−1.00% - 22
QuidelOrthoQDELDiagnostics maker behind VITROS analyzers and Sofia tests$1.01B−3.79% - 23
CeribellCBLLMaker of a bedside AI seizure-detection headband$900.4M+1.37% - 24
Fulgent GeneticsFLGTGenetic-testing lab pairing diagnostics with a cancer-drug pipeline$556.9M−1.65% - 25
Prenetics GlobalPREIM8 supplements and CircleDNA consumer testing$437.9M−1.79% - 26
Anbio BiotechnologyNNNNDesigner of decentralized diagnostic testing platforms$336.6M−2.63% - 27
Myriad GeneticsMYGNBRCA-rooted molecular diagnostics portfolio$298.5M−1.10% - 28
CapsoVisionCVPanoramic capsule endoscopy for small-bowel imaging$296.3M−1.98% - 29
OraSure TechnologiesOSUROraQuick tests and sample-management devices$247.9M−2.44% - 30
BiodesixBDSXBlood-based lung diagnostics and development services$218.4M−6.00% - 31
Trinity Biotech (ADR)TRIBDiagnostics maker for HIV and haemoglobin testing$196.0M−1.13% - 32
ExagenXGNAVISE diagnostics for autoimmune disease assessment$178.5M−1.86% - 33
StereotaxisSTXSRobotic magnetic navigation for cardiac electrophysiology$142.0M−1.36% - 34
Insight Molecular DiagnosticsIMDXMolecular testing for transplanted-organ rejection$133.4M−3.73% - 35
FreenomeFRNMMultiomic blood tests for early cancer screening$120.6M+6.03% - 36
StreamexSTEXCommodity-tokenization infrastructure and PURE EP electrophysiology$80.4M−7.08% - 37
SeraSERAPreterm-birth risk testing for pregnancy care$79.1M+1.72% - 38
MDxHealthMDXHMolecular prostate-cancer testing menu$37.0M−0.11% - 39
Quantum CyberQUCYAutonomous defense drones and counter-UAS systems$32.6M−2.72% - 40
CerenomeCNSYCNS cancer diagnostics and targeted radiotherapy$21.0M−1.94% - 41
Firefly NeuroscienceAIFFEEG assessment systems for clinical brain-function reports$16.0M+0.93% - 42
Bionano GenomicsBNGOOptical genome mapping systems and workflow software$13.4M−3.31% - 43
Advanced BiomedADVBFinancial-market AI systems amid biomedical divestiture$13.4M+1.88% - 44
Burning Rock Biotech (ADR)BNRNGS cancer diagnostics and biopharma testing$10.8M+0.80% - 45
BiomericaBMRAGI-focused diagnostics and rapid-test maker$6.6M+1.90% - 46
HeartSciencesHSCSAI-enabled ECG workflow platform and diagnostics developer$6.5M−2.88% - 47
Cardio DiagnosticsCDIOGenetic-epigenetic blood tests for coronary heart disease$5.5M−2.91% - 48
VolitionRxVNRXNucleosome and chromatin-based blood diagnostics$3.7M−10.80% - 49
Autonomix MedicalAMIXTransvascular peripheral-nerve sensing and ablation platform$2.9M−6.13% - 50
bioAffinity TechnologiesBIAFSputum-based lung diagnostics and pathology services$2.0M−3.75%

